Dublin, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The "Live Cell Imaging Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
Live Cell Imaging Global Market Report 2021: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global live cell imaging market.
The global live cell imaging market is expected to grow from $3.61 billion in 2020 to $3.98 billion in 2021 at a compound annual growth rate (CAGR) of 10.3%. The growth is mainly due to the increasing prevalence of chronic diseases which requires more efficient and quicker diagnostic facilities. The market is expected to reach $5.44 billion in 2025 at a CAGR of 8.13%.
Major players in the live cell imaging market are Leica Microsystems, Olympus Corporation, Sigma-Aldrich Corporation, PerkinElmer Inc., GE Healthcare, Carl Zeiss Meditec AG, Becton Dickinson and Company, Molecular Devices LLC, Bruker Corporation, Sartorius AG, Oxford Instruments, BioTek Instruments, Etaluma Inc, and CytoSMART Technologies.
The live cell imaging market consists of sales of live cell imaging by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing and selling live cell imaging equipment and consumables. Live cell imaging equipment helps in providing a detailed study of internal structures and cellular processes for understanding the cellular structures of cell biology. It also gives information on cells, proteins, and molecular interactions.
The main types of live cell imaging products include equipment, consumables, software. The technology used in live cell imaging is time-lapse microscopy, fluorescence recovery after photo bleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), others. Live cell imaging finds its applications in cell biology, developmental biology, stem cell and drug discovery, others. It is used in various sectors including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs).
North America was the largest region in the live cell imaging market in 2020. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Lack of skilled professionals is predicted to restraint the growth of the live cell imaging market. Live cell imaging technology requires highly skilled professionals to understand and study the functions of cells. According to Healthcare-in-Europe.com, an online platform that provides trends in medical technology, innovative procedures and advances in medical research, the UK and Europe are facing a serious shortage of lab skills over the next decade with medical laboratories among the worst affected.
Moreover, according to the research carried out by the Gatsby Foundation, the UK will need a further 700,000 technicians to support the economy by the end of 2030. Thus, the shortage of skilled professionals is likely to hinder market growth in the coming years.
In December 2020, PerkinElmer Inc., a USA-based company that focuses on diagnostics and includes capabilities of detection, imaging, informatics, and service acquired Horizon Discovery at an undisclosed amount. By combining the capabilities of Horizon with life science research of PerkinElmer and applied genomics portfolios, PerkinElmer will be able to deliver complete workflow solutions to life science customers working on drug discovery and development. Horizon Discovery is a UK-based gene-editing company.
The rising incidence of cancer is expected to drive the growth of the live cell imaging market in the forecast period. Cancer is the second major cause of death worldwide, accounting for one out of every six deaths each year. For example, cancer cases are projected to increase to 29.5 million and cancer-related deaths to 16.4 million worldwide by 2040.
In the United States, there were 16.9 million cancer patients in 2019, with the number expected to rise to 22.2 million by 2030. Live cell imaging technology plays a crucial role in the advancement and validation of cancer immunotherapy through visualization, characterization, and evaluation of the biological process of living cells. Therefore, the rising incidence of cancer fuels the growth of the live cell imaging market.
The countries covered in the Live Cell Imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Key Topics Covered:
1. Executive Summary
2. Live Cell Imaging Market Characteristics
3. Live Cell Imaging Market Trends and Strategies
4. Impact Of COVID-19 On Live Cell Imaging
5. Live Cell Imaging Market Size and Growth
5.1. Global Live Cell Imaging Historic Market, 2015-2020, Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Live Cell Imaging Forecast Market, 2020-2025F, 2030F, Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Live Cell Imaging Market Segmentation
6.1. Global Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
6.2. Global Live Cell Imaging Market, Segmentation By Technology , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
Fluorescence Recovery After Photobleaching (FRAP)
Fluorescence Resonance Energy Transfer (FRET)
High Content Screening (HCS)
6.3. Global Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
Stem Cell and Drug Discovery
6.4. Global Live Cell Imaging Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
7. Live Cell Imaging Market Regional and Country Analysis
7.1. Global Live Cell Imaging Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
7.2. Global Live Cell Imaging Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
Carl Zeiss Meditec AG
Becton Dickinson and Company
Molecular Devices LLC
For more information about this report visit https://www.researchandmarkets.com/r/8xtder
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900